Stay updated with breaking news from Sciad Communications. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Taipei, Taiwan, February 20th, 2023 / Sciad Newswire / BRIM Biotechnology, Inc. (BRIM, TPEx 6885), a clinical-stage company developing novel regenerative therapies to help combat and cure ophthalmology and degenerative joint diseases, is pleased to announce that Andrew Lin was elected as the new Chairman of the Boar...
London, UK, 8 February 2023 / Sciad Newswire / Empowered patients, robots and artificial intelligence are reshaping the pharmaceutical supply chain, says Dr Bertalan Meskó, Director of The Medical Futurist Institute. He will share insights on the trends influencing the future of the pharma...
Thuwal, Saudi Arabia, 2nd February 2023 / Sciad Newswire / Saudi Arabian mining company, Ma’aden, and King Abdullah University of Science and Technology (KAUST) Innovation Ventures fund invest $6 million USD collectively into Lithium Infinity (Lihytech), a startup who have developed an economically feasible way to e...
Taipei, Taiwan, 8th December 2022 / Sciad Newswire / BRIM Biotechnology, Inc. ("BRIM," TPEx 6885) is pleased to announce that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for BRM424 in the treatment of neurotrophic keratitis (NK), a rare degenerative eye disease which causes ve...
Taipei, Taiwan, 1st December 2022 / Sciad Newswire / BRIM Biotechnology, Inc. ("BRIM," TPEx 6885), a clinical-stage biotechnology company advancing novel regenerative therapies to help combat and cure ophthalmology and degenerative joint diseases, announced today that it has raised $20 million in its Series E fundin...